Treatment of infections caused by lincomycin-susceptible Gram-positive organisms
Each mL contains:
Lincomycin.............................100 mg
Exp. qs.........................................1 ml
Dogs and cats
For the treatment of infections caused by lincomycin-susceptible Gram-positive organisms, particularly Streptococci and Staphylococci, and certain Gram-negative anaerobic organisms e.g. Bacteroides spp. or Fusobacterium spp.
Tonsillitis, laryngitis and other upper respiratory tract infections: The product has proved effective against most causal organisms.
Abscesses, infected wounds and purulent dermatitis: The product has proved useful in clearing dermal infection since it readily penetrates tissues and maintains its action in the presence of purulent material.
Septicaemia: The product has been used successfully to combat septicaemic conditions caused by organisms sensitive to lincomycin.
For intramuscular or intravenous administration in dogs and cats.
Intramuscular: 22 mg/kg bwt once daily or 11 mg/kg bwt.
Intravenous: 11-22 mg/kg bwt once or twice daily by slow injection.
Withdrawal time: Not applicable.
Store in a cool and dry place. Avoid direct sunlight.
